Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography (PET)-based parameters in neoadjuvant chemoradiation treatment of esophageal carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2477-2481

  Ma, Jin Bo ^a   Chen, Er Cheng ^a   Song, Yi Peng ^a   Liu, Peng ^a   Jiang, Wei ^a   Li, Ming Huan ^b   Yu, Jin Ming ^b  

^a YANTAI YUHUANGDING HOSPITAL   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Chemoradiation; Esophageal cancer; Positron emission tomography; Prognostic factors

Indexed keywords

EID: 84880311768     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2477     Document Type: Article

References (18)

1. Akutsu Y, Matsubara H, Shuto K, et al (2009). Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patients. World J Surg, 33, 1002-9.
2. Becker K, Mueller JD, Schulmacher C, et al (2003). Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer, 98, 1521-30.
3. Cescon DW, Hopkins JP, Bradbury PA, et al (2009). Epidemiology of Esophageal Cancer: Molecular. Esophageal cancer: principles and practice, 93.
4. Chang F, Deere H, Mahadeva U, George S (2008). Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. Am J Clin Pathol, 129, 252-62.
5. Choi NC, Fischman AJ, Niemierko A, et al (2002). Doseresponse relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 54, 1024-35.
6. DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. Lippincott Williams & Wilkins2008.
7. Gillham CM, Lucey JA, Keogan M, et al (2006). (18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response. Br J Cancer, 95, 1174-9.
8. Heilmann HP, Molls M, Nieder C, et al. Radiation Oncology: An Evidence-based Approach. Springer 2008.
9. Hiyoshi Y, Watanabe M, Imamura Y, et al (2009). The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma. Oncology, 76, 286-92.
10. Javeri H, Xiao L, Rohren E, et al (2009a). Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer, 115, 624-30.
11. Javeri H, Xiao L, Rohren E, et al (2009b). The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer, 115, 5184-92.
12. Jingu K, Kaneta T, Nemoto K, et al (2010). (18) F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer. Int J Clin Oncol, 15, 184-90.
13. Kim MK, Ryu JS, Kim SB, et al (2007). Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Eur J Cancer, 43, 1385-91.
14. Klaeser B, Nitzsche E, Schuller JC, et al (2009). Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie, 32, 724-30.
15. Roedl JB, Harisinghani MG, Colen RR, et al (2008). Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography. Ann Thorac Surg, 86, 1131-8.
16. Schmidt M, Bollschweiler E, Dietlein M, et al (2009). Mean and maximum standardized uptake values in [18F]FDGPET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy. Eur J Nucl Med Mol Imaging, 36, 735-44.
17. Suzuki A, Xiao L, Hayashi Y, et al (2011). Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer, 117, 4823-33.
18. Tong DK, Law S, Kwong DL, et al (2010). Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann Surg Oncol, 17, 2184-92.